Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.419 USD | +0.24% | +3.18% | -2.58% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.19M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-0.55
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.12% |
Latest transcript on Theriva Biologics, Inc.
1 day | +0.24% | ||
1 week | +3.18% | ||
Current month | +4.10% | ||
1 month | -6.01% | ||
3 months | -21.74% | ||
6 months | -10.66% | ||
Current year | -2.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.419 | +0.24% | 27,706 |
24-05-07 | 0.418 | +4.50% | 50,904 |
24-05-06 | 0.4 | -0.74% | 38,166 |
24-05-03 | 0.403 | -3.59% | 40,611 |
24-05-02 | 0.418 | +2.94% | 36,163 |
Delayed Quote Nyse, May 08, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.58% | 7.17M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- TOVX Stock